Brain imaging research on subjective responses to psychotropic drugs

Acta Psychiatrica Scandinavica, Supplement

Volumn 111, Issue 427, 2005, Pages 22-28

  Voruganti, L P ^a,c   Awad, A G ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Dopamine; Dysphoria; Non compliance; Nucleus accumbens; Substance abuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; CATECHOLAMINE; COCAINE; DOPAMINE; HALOPERIDOL; METIROSINE; NICOTINE; OLANZAPINE; OPIATE; PSYCHOTROPIC AGENT; RISPERIDONE;

BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN RADIOGRAPHY; BRAIN REGION; CORPUS STRIATUM; CORRELATION ANALYSIS; DATA BASE; DEPRESSION; DIFFUSION TENSOR IMAGING; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPHORIA; EUPHORIA; HUMAN; NEUROANATOMY; NEUROCHEMISTRY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANCE ABUSE; WELLBEING; BRAIN; METABOLISM; VASCULARIZATION;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 20344389744     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00541.x     Document Type: Review

References (50)

1. KOEPP MJ, GUNN RN, LAWRENCE AD et al. Evidence for striatal dopamine release during a video game. Nature 1998;393:266-268.
2. VAN PUTTEN T. Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 1978;35:477-480.
3. AWAD AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull 1993;19:609-618.
4. VORUGANTI L, AWAD AG. Is drug induced extrapyramidal syndrome a variant of neuroleptic dysphoria? Can J Psychiatry 2004;49:285-289.
5. FIBIGER HC, PHILLIPS AG. Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In: MOUNTCASTLE VB, BLOOM FE, GEYER SR, EDS. Handbook of physiology: the nervous system IV. Bethesda, MD: American Physiological Society, 1986:647-675.
6. KOOB GF, LE MOAL M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24:97-129
7. PONTIERI FE, TANDA G, ORZI F, DI CHIARA G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996;382:255-277.
8. WISE RA. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988;97:118-132.
9. VOLKOW ND, FOWLER JS, WANG G-J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 1999;13:337-345.
10. 2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry 2000;157:1019-1020.
11. 2 receptor binding, motivation and attentiveness in humans: a replication study. Pharmacol Biochem Behav 2003;74:425-432.
12. VORUGANTI L, AWAD AG. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology (Berlin) 2004;171:121-131.
13. HEINZ A. Dopaminergic dysfunction in alcoholism and schizophrenia - psychopathological and behavioral correlates. Eur Psychiatry 2002;17:9-16.
14. 2 receptor levels. Am J Psychiatry 1999;156:1440-1443.
15. MODELL JG, MOUNTZ JM. Focal cerebral blood flow change during craving for alcohol measured by SPECT. J Neuropsychiatry Clin Neurosci 1995;7:15-22.
16. GRANT S, LONDON ED, NEWLIN DB et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 1996;93:12040-12045.
17. WANG GJ, VOLKOW ND, FRANCESCHI D et al. Regional brain metabolism during alcohol intoxication. Alcohol Clin Exp Res 2000;24:822-829.
18. KILTS CD, SCHWEITZER JB, QUINN CK et al. Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 2001;58:334-341.
19. VOLKOW ND, FOWLER JS, WANG GJ. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 1999;13:337-345.
20. GHATAN PH, INGVAR M, ERIKSSON L et al. Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berl) 1998;136:179-189.
21. ROBERTS RD, ROBBINS TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001;11:250-257.
22. VOLKOW ND, FOWLER JS, WANG GJ, GOLDSTEIN RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 2002;78:610-624.
23. LARUELLE M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-451.
24. BRODIE JD. Imaging for the clinical psychiatrist: facts, fantasies and other musings. Am J Psychiatry 1996;153:145-149.
25. FRISTON KJ. Imaging neuroscience: principles or maps? Proc Natl Acad Sci U S A 1998;95:796-802.
26. AVILA MT, CONLEY RR, CARPENTER WT. A comparison of symptom provocation procedures in psychiatry and other areas of medicine: implications for their ethical use in research. Biol Psychiatry 2001;50:479-486.
27. 123I]-iodebenzamide SPECT study. Br J Psychiatry 1997;171:574-577.
28. HIETALA J, SYVALAHTI E, VILKMAN H et al. Depressive symptoms and pre-synaptic dopamine function in neuroleptic naive schizophrenia. Schizophr Res 1999;35:41-50.
29. FUJITA M, VERHOEFF PLG, VARRONE A et al. Imaging extrastriatal dopamine D2 receptor occupancy by endogenous dopamine by healthy humans. Eur J Pharmacol 2000;387:179-188.
30. 2 binding ratio and dysphoric responses. Neuropsychopharmacology 2001;25:642-650.
31. HEINZ A, KNABLE MB, COPPOLA R et al. Psychomotor slowing negative symptoms and dopamine receptor availability - an IBZM SPECT study in neuroleptic treated and drug-free schizophrenic patients. Schizophr Res 1998;31:19-26.
32. 2 receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res 2002;56:31-36.
33. de HAAN L, VAN BRUGGEN M, LAVALAYE J, BOOIJ J, DINGEMANS PM, LINSZEN D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 2003;160:303-309.
34. 123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian partients: is it a marker of striatal pre-synaptic degeneration? Nucl Med Commun 1997;18:1115-1121.
35. 123I] beta-CIT) in untreated patients with suspicion of Parkinson's disease. J Investig Med 1997;45:448-452.
36. MARTINOT MLP, BRAGULAT V, ARTIGES E, DOLLE F, HINEN F, JOUVENT R, OTHERS. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 2001;158:314-316.
37. LAAKSO A, VILKMAN H, ALAKARE B et al. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry 2000;157:269-271.
38. LARUELLE M, ABI-DARGHAM A, VAN DYCK CH et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995;36:1182-1190.
39. VOLKOW ND, WANG GJ, FOWLER JS et al. Relationship between psycho-stimulant-induced 'high' and dopamine transporter occupancy. Proc Natl Acad Sci U S A 1996;93:10388-10392.
40. VOLKOW ND, WANG GJ, FOWLER JS et al. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 1999;291:409-415.
41. SCHLAEPFER TE, PEARLSON GD, WONG DF, MARENCO S, DANNALS RF. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997;154:1209-1213.
42. VOLKOW ND, WANG GJ, FISCHMAN MW et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;386:827-830.
43. VORUGANTI L, SLOMKA P, ZABEL P, MATTAR A, AWAD AG. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res (Neuroimaging) 2001;107:173-177.
44. 18F]-fluorodeoxyglucose. Arch Gen Psychiatry 1990;47:567-574.
45. PEARLSON GD, JEFFREY PJ, HARRIS GJ et al. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry 1993;150:495-497.
46. BREITER HC, GOLLUB RL, WEISSKOFF RM et al. Acute effects of cocaine on human brain activity and emotion. Neuron 1997;19:591-611.
47. VOLLENWEIDER FX, MAGUIRE RP, LEENDERS KL et al. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res 1998;83:149-162.
48. WANG GJ, VOLKOW ND, FRANCESCHI D et al. Regional brain metabolism during alcohol intoxication. Alcohol Clin Exp Res 2000;24:822-829.
49. MATTHEW RJ, WILSON WH, TANT SR. Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 1989;79:118-128.
50. VOLKOW ND, GILLESPIE H, MULLANI N et al. Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose. Psychiatry Res 1991;40:69-78.